Investment Strategy

Drovix Statistical Arbitrage

A fully systematic statistical arbitrage strategy trading global equities, using a broad range of statistical methods to generate consistent uncorrelated returns.

Strategy Overview

The Drovix Statistical Arbitrage strategy is a fully systematic equity market-neutral program that seeks to generate consistent, uncorrelated returns by exploiting short-term statistical mispricings in global equity markets. The strategy employs a broad range of statistical and machine learning methods across expansive datasets.

By maintaining a market-neutral posture, the strategy aims to deliver returns that are independent of overall market direction, providing valuable diversification benefits within institutional portfolios. The program trades across multiple developed and emerging equity markets.

Market Neutral

Returns independent of overall market direction

Global Equities

Trading across developed and emerging equity markets

Uncorrelated Returns

Low correlation to traditional asset classes and benchmarks

Diversified Signals

Multiple statistical models across varied data sources

Investment Approach

Alpha Generation

The strategy utilises a diverse set of quantitative signals derived from statistical methods including mean reversion, factor decomposition, and machine learning techniques. Signals are generated across multiple time horizons and combined through a proprietary portfolio optimisation framework.

Market Neutrality

The portfolio maintains a market-neutral exposure by balancing long and short positions. Sector, country, and factor exposures are carefully managed to ensure that returns are driven by stock-specific alpha rather than broad market movements.

Execution

Proprietary execution algorithms are used to minimise market impact and trading costs. The strategy benefits from the Company's institutional-grade execution infrastructure, with connectivity to major exchanges and liquidity venues globally.

Risk Management

Comprehensive risk management includes real-time monitoring of portfolio exposures, drawdown limits, position concentration limits, and liquidity constraints. Stress testing and scenario analysis are performed regularly to assess portfolio resilience.

Interested in This Strategy?

This strategy is available to institutional and professional investors. Contact our team to request detailed documentation, including performance track record, risk statistics, and terms of investment.

Contact Us

This page is for informational purposes only and does not constitute an offer or solicitation. Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. This information is intended for institutional and professional investors only.

Drovix

Drovix (MU) Ltd 获毛里求斯金融服务委员会(FSC)授权,持有不含承销业务的证券投资商(全面服务交易商)牌照,牌照编号 GB21026813。

公司通过 www.drovix.com 运营,注册地址为:C/o SALVUS (Mauritius) Ltd, Silver Bank Tower, Ground Floor, 18 Bank Street, Cybercity, Ebene 72201 Mauritius。

本网站仅面向机构及专业投资者。所载信息不构成在任何司法辖区内向任何人士发出的要约或招揽,若该等要约或招揽未获授权,或向该等人士作出要约或招揽属违法。

本网站所述产品及服务不向零售投资者提供。若您为零售投资者,请勿依赖本网站所载信息。

本网站信息仅供一般信息用途,不构成投资建议、推荐或买卖任何金融工具的要约。过往表现不代表未来结果。所有投资均涉及风险,包括可能损失本金。

本网站所载信息及服务并非面向或拟向任何国家或司法辖区的居民或国民分发,若该等分发或使用将违反当地法律或法规。

本信息并非面向受重大制裁的国家或司法辖区居民,包括但不限于阿富汗、白俄罗斯、古巴、伊朗、利比亚、缅甸、尼加拉瓜、朝鲜、俄罗斯、苏丹、叙利亚、委内瑞拉、也门及津巴布韦。

本网站提供的产品及服务并非面向澳大利亚、比利时、加拿大、法国、日本、马来西亚、波兰、乌克兰、英国或美国居民。本网站任何内容均不构成投资建议或参与任何投资活动的招揽。

版权所有 © 2026